HLB specializes in the development of innovative biopharmaceutical solutions, particularly focusing on targeted therapies for cancer. With a commitment to continuous innovation, HLB navigates the future of healthcare by developing first-in-class drugs. Their portfolio includes a range of products designed to meet unmet medical needs, particularly in the field of cancer treatment. HLB operates in various sectors including pharmaceuticals, biotechnology, healthcare, and more.
We're tracking 에이치엘비's market expansion
How 에이치엘비's international expansion compares to its competitors
에이치엘비YouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 에이치엘비You | 0 | 0 | — | 0 | 0 |
과장~차장급(팀원)
View postingSeoul, South Korea · 11mo ago
No tracked technology yet
Sign up to track this company and get alerted the moment something changes.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
KOSPI slightly up with institutional and individual buying. SK Hynix rises 2%. KOSDAQ turns negative. Last trading day for year-end dividends.
KOSPI fell to 2410 due to high exchange rates and political uncertainty. Foreign and institutional investors sold, while individuals bought. Major tech stocks declined.
KOSPI rose 0.31% to 2591.05 as US tariff concerns eased. Samsung Electronics up 0.4%. KOSDAQ also increased by 0.94% to 756.32.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about 에이치엘비's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.